- JP-listed companies
- StemCell Institute Inc.
- Balance sheet
StemCell Institute Inc.JP:7096
Market cap
¥8B
P/E ratio
24.8x
| 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 2,465 | 3,025 | 2,743 | 3,511 | 3,324 | 2,846 | 3,201 |
| Total current assets | - | 2,676 | 3,348 | 3,150 | 4,178 | 4,545 | 4,515 | 5,172 |
| Property, plant and equipment, net | - | 81 | 106 | 577 | 648 | 648 | 665 | 1,156 |
| Marketable securities, non-current | - | 0 | - | 105 | 105 | 243 | 513 | 648 |
| Total non-current assets | - | 138 | 217 | 808 | 1,037 | 1,266 | 2,028 | 2,328 |
| Total assets | - | 2,813 | 3,565 | 3,958 | 5,216 | 5,812 | 6,543 | 7,501 |
| Long-term debt, current | - | - | - | - | - | - | - | 62 |
| Total current liabilities | - | 1,831 | 2,302 | 2,589 | 3,052 | 3,432 | 3,760 | 4,318 |
| Long-term debt, non-current | - | - | - | - | - | - | - | 438 |
| Total non-current liabilities | - | - | 3 | 47 | 60 | 81 | 90 | 555 |
| Total liabilities | - | 1,831 | 2,305 | 2,636 | 3,112 | 3,513 | 3,850 | 4,873 |
| Common stock and paid-in capital | - | 635 | 635 | 635 | 1,295 | 1,295 | 1,295 | 1,295 |
| Retained earnings | - | 348 | 625 | 688 | 809 | 1,007 | 1,318 | 1,448 |
| Stockholders' equity | 840 | 982 | 1,260 | 1,322 | 2,104 | 2,299 | 2,693 | 2,628 |